Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Equity Ratio: 2019-2025

Historic Equity Ratio for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to -0.02.

  • Biodesix's Equity Ratio fell 107.16% to -0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.02, marking a year-over-year decrease of 107.16%. This contributed to the annual value of 0.21 for FY2024, which is 364.49% up from last year.
  • Latest data reveals that Biodesix reported Equity Ratio of -0.02 as of Q3 2025, which was down 249.64% from 0.01 recorded in Q2 2025.
  • Over the past 5 years, Biodesix's Equity Ratio peaked at 0.32 during Q1 2021, and registered a low of -0.09 during Q2 2023.
  • Over the past 3 years, Biodesix's median Equity Ratio value was 0.05 (recorded in 2023), while the average stood at 0.08.
  • Data for Biodesix's Equity Ratio shows a peak YoY increase of 1,727.28% (in 2024) and a maximum YoY decrease of 212.04% (in 2024) over the last 5 years.
  • Biodesix's Equity Ratio (Quarterly) stood at 0.26 in 2021, then fell by 14.44% to 0.22 in 2022, then slumped by 79.16% to 0.05 in 2023, then skyrocketed by 364.49% to 0.21 in 2024, then tumbled by 107.16% to -0.02 in 2025.
  • Its last three reported values are -0.02 in Q3 2025, 0.01 for Q2 2025, and 0.13 during Q1 2025.